Clinical study on effect of zhifeng huatan pingxiao recipe in treating attack stage of child asthma.
- Author:
Ke-jing CHEN
1
;
Xiao-mei HAO
;
Mei LIU
Author Information
- Publication Type:Clinical Trial
- MeSH: Adolescent; Asthma; blood; drug therapy; Child; Child, Preschool; Drugs, Chinese Herbal; therapeutic use; Endothelins; blood; Eosinophils; Female; Humans; Immunoglobulin E; blood; Leukocyte Count; Male; Phytotherapy
- From: Chinese Journal of Integrated Traditional and Western Medicine 2003;23(9):673-675
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the therapeutic effect of Zhifeng Huatan Pingxiao recipe (ZHPR) in treating attack stage of child asthma.
METHODSSixty child asthma patients with attack of mild and moderate degree were randomly divided into the treated group (40 patients treated with ZHPR) and the control group (20 patients treated with western medicine). The therapeutic effect and laboratory indexes, including peripheral eosinophil count (EOS), serum immunoglobulin E (IgE) and plasma endothelin (ET), before and after treatment were observed.
RESULTSThe total effective rate in the treated group was 72.5%, which was not different to that in the control group (P > 0.05). The therapeutic effect between different TCM types (heat and cold types) in the treated group was not different significantly (P > 0.05). ET, IgE and EOS levels all lowered after treatment in the treated group, but as compared with those in the control group, the difference was insignificant (P > 0.05).
CONCLUSIONThe therapeutic effect of ZHPR in treating child asthma attack stage is equivalent to that of western medicine, it shows actions in improving laboratory indexes.
